Physician profile
John B Alder
NPI 1508829144
$1,927.75
in general payments reported to CMS, 2019-2025
18 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $70.66 · 2021: $313 · 2022: $165 · 2023: $400 · 2024: $264 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $538.31 | 2019-2025 | Tryptyr, Clareon, Rocklatan |
| Sun Pharmaceutical Industries INC. | $422.47 | 2019-2025 | Cequa, Xelpros |
| Kala Pharmaceuticals, INC. | $201.99 | 2021 | |
| Bausch & Lomb Americas INC. | $177.25 | 2024-2025 | Vyzulta |
| Novartis Pharmaceuticals Corporation | $127.39 | 2019-2023 | |
| Allergan, INC. | $124.69 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $81.52 | 2019-2025 | |
| Apellis Pharmaceuticals, INC. | $47.38 | 2025 | Syfovre |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $31.41 | 2019 | |
| Biotissue Holdings INC. | $27.02 | 2021 | |
| Merck Sharp & Dohme LLC | $22.82 | 2022 | |
| Spark Therapeutics, INC. | $20.90 | 2022 | |
| Astellas Pharma US INC | $20.22 | 2024 | Izervay |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Akorn, INC. | $18.66 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.06 | 2023 | Alphagan P, Vuity |
| Thea Pharma INC. | $15.84 | 2025 | Iyuzeh |
| Shire North American Group INC | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Alder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.